CLINICAL ROLE -
Hepatitis C Drug Dominos Continue to Fall as More Agreements Reached
CVS and Prime Therapeutics agreements follow Express Scripts in hepatitis C formulary updates.
Read More
British Health Service Cuts Access to Certain Cancer Drugs
Government office cuts 16 drugs amid funding problems.
The British National Health Service announced yesterday that it will drop 16 cancer drugs from the list of treatments funded through its Cancer Drugs Fund.
Researchers Find Potential Target to Treat Several Diseases
Attacking protein could potentially treat a number of conditions, including the Ebola virus, brain cancer, and hepatitis.
Prostate Cancer Survival Prolonged by Radiation Plus Hormone Therapy
Study finds many patients not receiving radiation treatment.
Nearly 10 Million Would Lose Health Insurance if ACA Subsidies Axed
Supreme Court to decide legality of offering subsidies to low- and moderate-income people who purchase coverage through federally run health insurance marketplaces.
Stem Cell Transplants Result in Sustained Multiple Sclerosis Remission
Most patients treated with high-dose immunosuppressive therapy and who had their own hematopoietic stem cells transplanted experienced sustained remission after 3 years.
Killing Cancer Cells Through the Biological Clock
Targeted therapy found to shrink tumor growth.
How Does Chemo and Hormonal Therapy Effect Brains of Breast Cancer Patients?
Side effects found to make it harder for patients to concentrate.
FDA Committee Recommends First Biosimilar Approval
Filgrastim is indicated to decrease the incidence of infection in patients with non-myeloid malignancies who also are receiving myelosuppressive anti-cancer drugs.
Neonatal HBV Vaccine Reduces Liver Disease in Young Adults
Hepatitis B vaccination reduces incidence of primary liver cancer by 84% later in life, study finds.
Pharmaceutical manufacturing in the United States inched a step closer to a historic milestone today when the FDA Oncologic Drugs Advisory Committee recommended approval of the investigational biosimilar, filgrastim.
Blood Cancer Treatment Granted Orphan Drug Designation
Drug currently being evaluated for treatment of hematological malignancies.
Specialty Pharmacy: What Pharmacy Students Should Know
Specialty pharmacy is growing, and student pharmacists should keep abreast of the latest industry trends.
The FDA today granted orphan drug designation to an experimental drug that treats several types of blood cancers.
HIV Inhibitor Blocks Infection
Research may lead to targeted therapeutic approach.
Why Are Certain Cancer Cells Resistant to Therapy?
Researchers seek better targets for blocking events that lead to drug resistance.
HIV Impacts Patient Hearing
Study finds disease leads to worse low and high frequency hearing.
Experimental Treatment Effective Against Aggressive Leukemia
Drug found to be as effective as current treatment without serious side effects.
Multiple Myeloma Drug Combo Yields Unprecedented Results
Carfilzomib added to 2-drug combination produces longer remission period.
How to Boost Healthy Cells During Chemotherapy
Adding a building block found in DNA could aid healthy cell production in cancer patients, study finds.
Specialized Apheresis Therapy Holds Promise in Cancer Treatment
Study finds drawing blood can be a powerful therapeutic in extracorporeal photopherisis.
Trial Provides Hope for Rare Disease Drug Development
Combinations of drugs already approved found to be safe in treatment of rare disease.
New Treatment Options on Horizon for Early Relapse Prostate Cancer Patients
Vaccine therapy stimulates immune defenses.
How Does Heroin Use Impact HIV Infection
Study suggests drug has negative impact on immune system.
Express Scripts to Cover Viekira Pak, Exclude Sovaldi
Multi-year agreement with AbbVie will place new drug as the exclusive option for patients with hepatitis C genotype 1.
Hodgkin Lymphoma Treatment Could Enhance Standard of Care
Patients who received brentuximab vedotin post-transplant lived longer without disease progression than those on supportive care.
As Private Health Care Prices Go Down, Medicare Spending Goes Up
Study finds doctors shift health care services to Medicare when they can profit from doing so.
FDA Grants Melanoma Drug Accelerated Approval
Nivolumab treats patients with unresectable or metastatic melanoma who no longer respond to other drugs.
How to Get New Ovarian Cancer Treatment to Patients
Olaparib (Lynparza) was approved with companion diagnostic that detects mutations in BRCA genes.